Medifast Inc (MED) Stock Price, Quote & News

Company Profile

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding,...

Industry: Personal Services

Sector: Consumer Cyclical

Phone: 410 581 8042

Website: medifastinc.com

Address:

100 International Drive, 18th Floor, Baltimore, United States

justcomments Jan. 9 at 7:07 PM

$MED GLP1=Pancreatitis cancer. Thyroid cancer. Kidney damage. Heart failure. Gastrointestinal paralysis. Eye problems. BUY MED

0 · Reply

Hanse2014 Jan. 9 at 4:55 PM

$MED :As 2025 came to a close, our teams across Medifast took time to gather together and honor what we have accomplished throughout the year. Thank you to all our team members for bringing momentum into 2026. From our Medifast team to you, wishing you a strong start to the new year!" I want to see momentum!!

0 · Reply

Amolosricha1 Jan. 9 at 2:51 AM

$NVO $LLY $MED I thought quitting diets lead to fast weight regain but quitting GLP-1 is even 4 times as fast. Weight loss drugs suck. this is the news: https://themorningnews.com/news/2026/01/08/weight-loss-drugs-end-weight-piled-back-4x-faster-than-dieting-study-finds/

7 · Reply

VanDownByTheRiver Jan. 8 at 8:26 PM

$LLY $MED $NVO

0 · Reply

Amolosricha1 Jan. 8 at 8:20 PM

$LLY $NVO $MED GLP-1 weight loss drug sucks. Everybody stops taking these drugs after 1 year. The side effects are just too high, so they quit. You can throw the pill into the garbage bin. People are not dumb, they will realize this. Death to the GLP-1 hype is comming...

3 · Reply

ZacksResearch Jan. 8 at 5:54 PM

$MED isn’t just chasing weight loss — it’s aiming bigger. 🚨 Metabolic health could be the real growth lever. Medifast is pivoting toward metabolic health, leaning on clinical data and new products to tackle root causes rather than relying solely on GLP-1 weight loss trends. Durable growth story or strategic reset? Find out here 👉 https://www.zacks.com/stock/news/2814558/medifast-shifts-to-metabolic-health-a-durable-growth-path?cid=sm-stocktwits-2-2814558-teaser-28065&ADID=SYND_STOCKTWITS_TWEET_2_2814558_TEASER_28065

0 · Reply

ZacksResearch Jan. 8 at 4:54 PM

$MED's strategic shift: Can its metabolic health focus lead to long-term growth? 🤔 Despite Medifast's innovative approach to metabolic health, shares are down 29.5% in 6 months and it holds a Zacks Rank #4 (Sell). The company's forward P/S ratio of 0.33 is well below the industry average. 📉 Full analysis here 👉 https://www.zacks.com/stock/news/2814558/medifast-shifts-to-metabolic-health-a-durable-growth-path?cid=sm-stocktwits-2-2814558-body-28067&ADID=SYND_STOCKTWITS_TWEET_2_2814558_BODY_28067

0 · Reply

justcomments Jan. 7 at 10:39 PM

$MED looks like a tax loss harvesting candidate for 2026 return. I was hoping for a better outcome, but this is almost hopeless.

0 · Reply

Mr__G Jan. 5 at 2:33 PM

$MED Finaly a new CEO ! Thank the Lord.

1 · Reply

ZacksResearch Dec. 30 at 7:11 PM

Medifast's $MED shares down 28.2% in 6 months — Is it time to reconsider? 🤔 🔍 MED is shifting from weight-loss to metabolic health, but it carries a Zacks Rank #4 (Sell). 📉 Forward P/S ratio of 0.33 vs. industry average of 1.05 suggests undervaluation, yet earnings are projected to decline. Understand the risks before investing in MED 👉 https://www.zacks.com/stock/news/2810456/medifast-new-product-line-planned-can-innovation-reignite-demand?cid=sm-stocktwits-2-2810456-body-26908&ADID=SYND_STOCKTWITS_TWEET_2_2810456_BODY_26908

0 · Reply

Medifast Announces Planned Leadership Transition

Dec 9, 2025, 8:30 AM EST - 5 weeks ago

OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing

Nov 13, 2025, 4:30 PM EST - 2 months ago

Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference

Nov 3, 2025, 6:36 PM EST - 2 months ago

Medifast, Inc. (MED) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 4:05 PM EST - 2 months ago

Medifast Announces Third Quarter 2025 Financial Results

Oct 27, 2025, 8:30 AM EDT - 2 months ago

Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™

Oct 21, 2025, 10:00 AM EDT - 3 months ago

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025

Sep 15, 2025, 8:30 AM EDT - 4 months ago

Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes

Aug 4, 2025, 11:56 PM EDT - 5 months ago

Medifast, Inc. (MED) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 4:05 PM EDT - 5 months ago

Medifast Announces Second Quarter 2025 Financial Results

LFMD

Jul 21, 2025, 4:05 PM EDT - 6 months ago

Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025

Jul 3, 2025, 2:48 AM EDT - 6 months ago

Medifast: Coach Surge Fuels Growth

Apr 28, 2025, 6:03 PM EDT - 9 months ago

Medifast, Inc. (MED) Q1 2025 Earnings Call Transcript

Apr 28, 2025, 4:05 PM EDT - 9 months ago

Medifast Announces First Quarter 2025 Financial Results

LFMD

Mar 28, 2025, 9:21 AM EDT - 10 months ago

Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect

Feb 18, 2025, 7:06 PM EST - 11 months ago

Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 4:05 PM EST - 11 months ago

Medifast Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 4, 2025, 4:05 PM EST - 1 year ago

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024

Jan 7, 2025, 8:30 AM EST - 1 year ago

Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off

Dec 5, 2024, 8:30 AM EST - 1 year ago

Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications

Nov 6, 2024, 8:02 AM EST - 1 year ago

Medifast: Earnings Surprise, New AI Technologies, And Extremely Undervalued

Nov 4, 2024, 5:56 PM EST - 1 year ago

Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 1 year ago

Medifast Announces Third Quarter 2024 Financial Results

Oct 21, 2024, 4:05 PM EDT - 1 year ago

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

Oct 3, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.

Oct 1, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Shareholders To Join An Inquiry Into Medifast, Inc. For Possible Securities Fraud

Sep 30, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Sep 28, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm

Sep 27, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.

Sep 26, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Investors Are Urged To Contact The Schall Law Firm

Sep 25, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Medifast, Inc. For Possible Securities Fraud

Sep 24, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

Sep 21, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Medifast, Inc. For Securities Fraud

Sep 20, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc May Have Violated Securities Laws And Investors Are Urged To Help The Schall Law Firm Investigate

Sep 19, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Seeks Shareholder Participation In An Inquiry Into Medifast, Inc. For Possible Securities Fraud

Sep 17, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Seeks Shareholder Contributions To A Securities Fraud Inquiry Into Medifast, Inc.

Sep 15, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. May Have Defrauded The Public And The Schall Law Firm Invites Stockholders To Join A Securities Fraud Inquiry

$The Schall Law Firm Is Investigating Medifast Inc's Possible Securities Related Infractions And Affected Investors Can Partake$

Sep 14, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Investigating Medifast Inc's Possible Securities Related Infractions And Affected Investors Can Partake

Sep 13, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. May Have Committed Securities Fraud And Shareholders With Losses Are Urged To Contribute To The Schall Law Firm's Inquiry

$The Schall Law Firm Is Looking Into Medifast Inc's Possible Securities Law Infractions And Investors Are Invited To Reach Out$

Sep 12, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Medifast Inc's Possible Securities Law Infractions And Investors Are Invited To Reach Out

Sep 11, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. May Have Committed Securities Fraud And Shareholders Can Join The Schall Law Firm's Inquiry

Sep 9, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. Might Have Committed Securities Fraud And Impacted Shareholders Can Join The Schall Law Firm's Inquiry

Sep 7, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Whether Medifast Inc Violated Securities Laws And Investors Can Partake In The Investigation

Sep 5, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Might Have Committed Securities Fraud And Investors Should Join The Schall Law Firm's Investigation

Sep 4, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Laws And Impacted Shareholders Can Reach Out

justcomments Jan. 9 at 7:07 PM

$MED GLP1=Pancreatitis cancer. Thyroid cancer. Kidney damage. Heart failure. Gastrointestinal paralysis. Eye problems. BUY MED

0 · Reply

Hanse2014 Jan. 9 at 4:55 PM

0 · Reply

Amolosricha1 Jan. 9 at 2:51 AM

7 · Reply

VanDownByTheRiver Jan. 8 at 8:26 PM

$LLY $MED $NVO

0 · Reply

Amolosricha1 Jan. 8 at 8:20 PM

3 · Reply

ZacksResearch Jan. 8 at 5:54 PM

0 · Reply

ZacksResearch Jan. 8 at 4:54 PM

0 · Reply

justcomments Jan. 7 at 10:39 PM

$MED looks like a tax loss harvesting candidate for 2026 return. I was hoping for a better outcome, but this is almost hopeless.

0 · Reply

Mr__G Jan. 5 at 2:33 PM

$MED Finaly a new CEO ! Thank the Lord.

1 · Reply

ZacksResearch Dec. 30 at 7:11 PM

0 · Reply

ZacksResearch Dec. 30 at 6:11 PM

New product launch for MED — can innovation spark demand again? 👀 This could be a turning point. $MED plans a new product line rooted in metabolic synchronization science, upgrading its core offerings as it shifts beyond weight loss — a strategic move aimed at refreshing demand. Can this reset the growth story? Find out here 👉 https://www.zacks.com/stock/news/2810456/medifast-new-product-line-planned-can-innovation-reignite-demand?cid=sm-stocktwits-2-2810456-teaser-26895&ADID=SYND_STOCKTWITS_TWEET_2_2810456_TEASER_26895

0 · Reply

MetroMyth Dec. 27 at 3:20 PM

$MED Positioning reflects caution while awaiting confirmable progress; customer retention trends will be critical to monitor — improving transparency could compress perceived risk. Patience helps only if fundamentals keep strengthening.

0 · Reply

ZacksResearch Dec. 24 at 7:24 PM

$MED struggles with a 36.2% revenue drop — is recovery in sight? 📉 👥 Coach base shrinks by 35%, impacting sales 🛠️ Rightsizing actions in place to stabilize margins 📈 Expected inflection point in Q4 of fiscal 2025 as initiatives kick in Discover the full story here 👉 https://www.zacks.com/stock/news/2808820/medifasts-third-quarter-revenue-fell-36-is-stabilization-near?cid=sm-stocktwits-2-2808820-body-26325&ADID=SYND_STOCKTWITS_TWEET_2_2808820_BODY_26325

0 · Reply

ZacksResearch Dec. 24 at 6:24 PM

$MED just saw Q3 revenue drop 36% — but is the bottom finally forming? ⚠️ Medifast’s revenue plunged as its coach base shrank, yet restructuring and productivity initiatives are aimed at stabilizing results by late 2025. The setup is ugly, but the turnaround angle is clearly being framed. See whether stabilization is realistic 👉 https://www.zacks.com/stock/news/2808820/medifasts-third-quarter-revenue-fell-36-is-stabilization-near?cid=sm-stocktwits-2-2808820-teaser-26295&ADID=SYND_STOCKTWITS_TWEET_2_2808820_TEASER_26295

0 · Reply

SuperGreenToday Dec. 23 at 9:32 PM

$MED Share Price: $11.15 Contract Selected: Jun 18, 2026 $10 Calls Buy Zone: $1.57 – $1.94 Target Zone: $2.75 – $3.36 Potential Upside: 65% ROI Time to Expiration: 176 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

ZacksResearch Dec. 18 at 5:26 PM

GLP-1 pressure is real — can $MED fight back? ⚠️💪 MED is leaning into long-term metabolic health, pushing programs designed to preserve muscle and support lasting wellness as GLP-1 adoption grows. Can this growth strategy hold up against the GLP-1 wave? Find out here 👉 https://www.zacks.com/stock/news/2806338/can-medifast-overcome-glp-1-pressure-with-its-growth-strategy?cid=sm-stocktwits-2-2806338-teaser-25452&ADID=SYND_STOCKTWITS_TWEET_2_2806338_TEASER_25452

0 · Reply

ZacksResearch Dec. 18 at 4:26 PM

$MED down 14.1% in 6 months — is it time to pivot to growth? 📉 Medifast is focusing on metabolic health and digital tools to address evolving weight-loss dynamics, yet it carries a Zacks Rank #4 (Sell). Meanwhile, $COCO boasts Zacks Rank #1, with impressive growth and earnings surprises, and $MNST sports a Zacks Rank #1. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2806338/can-medifast-overcome-glp-1-pressure-with-its-growth-strategy?cid=sm-stocktwits-2-2806338-body-25453&ADID=SYND_STOCKTWITS_TWEET_2_2806338_BODY_25453

0 · Reply

Mr__G Dec. 13 at 1:15 PM

$MED they have 173mil in Cash and short term investment 🤣

0 · Reply

Jumpy58 Dec. 10 at 6:58 PM

$MED I think this stock has a future. In my opinion, the worst is over and I'm confident in a slow turnaround. My sentiment is improving. I'm confident

0 · Reply

justcomments Dec. 9 at 2:59 PM

$MED bouncing? Unheard of.

0 · Reply

Mr__G Dec. 5 at 4:07 PM

$MED just buyback some shares, bring back good momentum, that helps the whole company

0 · Reply

bginvest Dec. 4 at 8:40 PM

$MED $OTLY if i should put money in this sector health food ( waiting ) I would recommend OTLY at this point but I am personally only watching right now MED is shrinking as a company for longer period without profit there probably is continuing OTLY is growing but are expensive compared with other growth companies But if I should choose one it would be OTLY anytime I am staying on the sideline and hoping for a investment in OTLY when it’s closer to be profitable and if there still is growth they could’ve a bright future but still need money growth Best of luck 😘🤞🏦

1 · Reply

Market Cap	128.49M
Revenue (ttm)	602.46M
Net Income (ttm)	2.09M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.35%
Debt to Equity Ratio	0.00

Volume	199,300
Avg Vol	250,928
Day's Range	N/A - N/A
Shares Out	10.99M
Stochastic %K	97%
Beta	0.48
Analysts	Hold
Price Target	$15.00